Aerosolized Medications for Gene and Peptide Therapy

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Respiratory care

• Publication date

  2015-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.4187/respcare.03554PMID 26070576
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Small interfering RNA (siRNA)

  2014cited by this paper
• The expanding role of aerosols in systemic drug delivery, gene therapy and vaccination: an update

  2014cited by this paper
• Inhalation treatment with glutathione in patients with cystic fibrosis. A randomized clinical trial.

  2013cited by this paper
• Expert opinion in biological therapy: update on developments in lung gene transfer

  2013cited by this paper
• Moving forward: cystic fibrosis gene therapy.

  2013influential reference
• Recent advances in α-1-antitrypsin deficiency-related lung disease

  2013cited by this paper
• Vasoactive intestinal Peptide inhaled agonists: potential role in respiratory therapeutics.

  2013cited by this paper
• A randomised, double-blind, placebo-controlled phase IIB clinical trial of repeated application of gene therapy in patients with cystic fibrosis

  2013cited by this paper
• Conference report: 2nd Medicon Valley Inhalation Symposium.

  2013cited by this paper
• Further experimentation of inhaled; LANTUS, ACTRAPID and HUMULIN with todays' production systems.

  2013cited by this paper
• Progress in gene and cell therapy for cystic fibrosis lung disease.

  2012cited by this paper
• Vectors for Inhaled Gene Therapy in Lung Cancer. Application for Nano Oncology and Safety of Bio Nanotechnology

  2012cited by this paper
• Feasibility and effectiveness of inhaled carboplatin in NSCLC patients

  2012cited by this paper
• Fracture prevention in postmenopausal women.

  2011cited by this paper
• Targeted Therapy in Lung Cancer: Lessons Learned from Past Experiences

  2011cited by this paper
• Aerosolized Gemcitabine in Patients with Carcinoma of the Lung: Feasibility and Safety Study

  2011cited by this paper
• Physical properties, lung deposition modeling, and bioactivity of recombinant GM-CSF aerosolised with a highly efficient nebulizer.

  2011cited by this paper
• Inhalable nanoparticles, a non-invasive approach to treat lung cancer in a mouse model.

  2011cited by this paper
• Inhaled granulocyte/macrophage-colony stimulating factor as therapy for pulmonary alveolar proteinosis.

  2010cited by this paper
• Phase I/II Study of Inhaled Doxorubicin Combined with Platinum-Based Therapy for Advanced Non–Small Cell Lung Cancer

  2010cited by this paper
• Inhaled vasoactive intestinal peptide exerts immunoregulatory effects in sarcoidosis.

  2010cited by this paper
• Inhibition of lung tumor growth by complex pulmonary delivery of drugs with oligonucleotides as suppressors of cellular resistance

  2010cited by this paper
• Comparison of the type of liposome involving cytokine production induced by non-CpG Lipoplex in macrophages.

  2010cited by this paper
• The I-neb Adaptive Aerosol Delivery System Enhances Delivery of α1-Antitrypsin with Controlled Inhalation

  2010cited by this paper
• Pulmonary targeting microparticulate camptothecin delivery system: anticancer evaluation in a rat orthotopic lung cancer model

  2010cited by this paper
• Chemical vectors for gene delivery: uptake and intracellular trafficking.

  2010cited by this paper
• Prandial inhaled insulin plus basal insulin glargine versus twice daily biaspart insulin for type 2 diabetes: a multicentre randomised trial.

  2010cited by this paper
• Uptake of all-trans retinoic acid–containing aerosol by inhalation to lungs in a guinea pig model system—A pilot study

  2010cited by this paper
• A Review of Inhaled Technosphere Insulin

  2010cited by this paper
• Biological gene delivery vehicles: beyond viral vectors.

  2009cited by this paper
• Combination Chemotherapeutic Dry Powder Aerosols via Controlled Nanoparticle Agglomeration

  2009cited by this paper
• Lipid nanocapsules: ready-to-use nanovectors for the aerosol delivery of paclitaxel.

  2009cited by this paper
• Gene transfer to the lung: lessons learned from more than 2 decades of CF gene therapy.

  2009cited by this paper
• Intrapulmonary delivery of XCL1-targeting small interfering RNA in mice chronically infected with Mycobacterium tuberculosis.

  2009influential reference
• Lung deposition of inhaled α1-proteinase inhibitor in cystic fibrosis and α1-antitrypsin deficiency

  2009cited by this paper
• siRNA vs. shRNA: similarities and differences.

  2009cited by this paper
• The use of biotinylated-EGF-modified gelatin nanoparticle carrier to enhance cisplatin accumulation in cancerous lungs via inhalation.

  2009cited by this paper
• Aerosolized Chemotherapy

  2008cited by this paper
• Feasibility and Safety of Targeted Cisplatin Delivery to a Select Lung Lobe in Dogs via the AeroProbe® Intracorporeal Nebulization Catheter

  2008cited by this paper
• Global tuberculosis control: surveillance planning financing. WHO report 2008.

  2008cited by this paper
• The Vasoactive Intestinal Peptide Gene Is a Key Modulator of Pulmonary Vascular Remodeling and Inflammation

  2008cited by this paper
• Small Interfering RNA (siRNA)

  2008cited by this paper
• Efficacy and Safety of Technosphere Inhaled Insulin Compared With Technosphere Powder Placebo in Insulin-Naive Type 2 Diabetes Suboptimally Controlled With Oral Agents

  2008cited by this paper
• Inhalation of vasoactive intestinal peptide in pulmonary hypertension

  2008cited by this paper
• Improvement in clinical markers in CF patients using a reduced glutathione regimen: an uncontrolled, observational study.

  2008cited by this paper
• Clinical Research Observations with Use of Exubera in Patients with Type 1 and 2 Diabetes

  2007cited by this paper
• Phase I Study of Aerosolized SLIT Cisplatin in the Treatment of Patients with Carcinoma of the Lung

  2007cited by this paper
• Phase I Study of Inhaled Doxorubicin for Patients with Metastatic Tumors to the Lungs

  2007cited by this paper
• The Design and Performance of the Exubera® Pulmonary Insulin Delivery System

  2007cited by this paper
• Review of Phase 2 Studies Utilizing the AIR® Particle Technology in the Delivery of Human Insulin Inhalation Powder Versus Subcutaneous Regular or Lispro Insulin in Subjects with Type 1 or Type 2 Diabetes

  2007cited by this paper
• Delivering Needle-Free Insulin Using AERx® iDMS (Insulin Diabetes Management System) Technology

  2007cited by this paper
• Repeated Aerosolized AAV-CFTR for Treatment of Cystic Fibrosis: A Randomized Placebo-Controlled Phase 2B Trial

  2007cited by this paper
• Toward Therapies Tailored to Patient Characteristics

  2007cited by this paper
• The AIR® Inhaled Insulin System: System Components and Pharmacokinetic/Glucodynamic Data

  2007cited by this paper
• Drug penetration in solid tumours

  2006cited by this paper
• Aerosol granulocyte-macrophage colony-stimulating factor for pulmonary alveolar proteinosis

  2006cited by this paper
• Assessing a System to Capture Stray Aerosol during Inhalation of Nebulized Liposomal Cisplatin

  2006cited by this paper
• Suppression of Discoidin Domain Receptor 1 by RNA Interference Attenuates Lung Inflammation1

  2006cited by this paper
• Mice lacking the VIP gene show airway hyperresponsiveness and airway inflammation, partially reversible by VIP.

  2006cited by this paper
• Pharmacokinetics of 5-fluorouracil in the hamster following inhalation delivery of lipid-coated nanoparticles.

  2006cited by this paper
• Hyperoxia causes angiopoietin 2–mediated acute lung injury and necrotic cell death

  2006cited by this paper
• Formulation and cytotoxicity of doxorubicin nanoparticles carried by dry powder aerosol particles.

  2006cited by this paper
• The Expanding Role of Aerosols in Systemic Drug Delivery, Gene Therapy, and Vaccination

  2005cited by this paper
• Aerosol delivery of chemotherapy in an orthotopic model of lung cancer

  2005cited by this paper
• A pilot study of the effect of inhaled buffered reduced glutathione on the clinical status of patients with cystic fibrosis.

  2005cited by this paper
• Spray-dried poly(D,L-lactide) microspheres containing carboplatin for veterinary use: In vitro and in vivo studies

  2005cited by this paper
• Granulocyte-macrophage colony-stimulating factor and lung immunity in pulmonary alveolar proteinosis.

  2005cited by this paper
• Small interfering RNA for experimental cancer therapy.

  2005cited by this paper
• In vivo gene silencing (with siRNA) of pulmonary expression of MIP‐2 versus KC results in divergent effects on hemorrhage‐induced, neutrophil‐mediated septic acute lung injury

  2005cited by this paper
• alpha1-Antitrypsin deficiency . 6: new and emerging treatments for alpha1-antitrypsin deficiency.

  2004cited by this paper
• Chemoprevention of Cancer of the Upper Respiratory Tract of the Syrian Golden Hamster by Aerosol Administration of Difluoromethylornithine and 5-Fluorouracil

  2004cited by this paper
• Repeated adeno-associated virus serotype 2 aerosol-mediated cystic fibrosis transmembrane regulator gene transfer to the lungs of patients with cystic fibrosis: a multicenter, double-blind, placebo-controlled trial.

  2004cited by this paper
• Clinical Evaluation of the Delivery and Safety of Aerosolized Liposomal 9-Nitro-20(S)-Camptothecin in Patients with Advanced Pulmonary Malignancies

  2004cited by this paper
• Cyclosporin A aerosol improves the anticancer effect of paclitaxel aerosol in mice.

  2004cited by this paper
• Small Interfering RNA Targeting Heme Oxygenase-1 Enhances Ischemia-Reperfusion-induced Lung Apoptosis*

  2004cited by this paper
• Novel vitamin E analogue and 9-nitro-camptothecin administered as liposome aerosols decrease syngeneic mouse mammary tumor burden and inhibit metastasis

  2004cited by this paper
• Improvement of alveolar glutathione and lung function but not oxidative state in cystic fibrosis.

  2004cited by this paper
• α-TEA Plus Cisplatin Reduces Human Cisplatin-Resistant Ovarian Cancer Cell Tumor Burden and Metastasis

  2004cited by this paper
• α1-Antitrypsin deficiency · 6: New and emerging treatments for α1-antitrypsin deficiency

  2004cited by this paper
• Cyclosporin A Aerosol Improves the Anticancer Effect of Paclitaxel Aerosol in Mice

  2004cited by this paper
• Paclitaxel (taxol) and taxoid derivates for lung cancer treatment: potential for aerosol delivery.

  2003cited by this paper
• RNA interference may be more potent than antisense RNA in human cancer cell lines

  2003cited by this paper
• RNAi as a gene therapy approach

  2003cited by this paper
• High-affinity autoantibodies specifically eliminate granulocyte-macrophage colony-stimulating factor activity in the lungs of patients with idiopathic pulmonary alveolar proteinosis.

  2003cited by this paper
• Comparison of the Suppressive Effects of Antisense Oligonucleotides and siRNAs Directed Against the Same Targets in Mammalian Cells

  2003cited by this paper
• Efficient Reduction of Target RNAs by Small Interfering RNA and RNase H-dependent Antisense Agents

  2003cited by this paper
• Vasoactive intestinal peptide as a new drug for treatment of primary pulmonary hypertension.

  2003cited by this paper
• Nitric oxide and vasoactive intestinal peptide as co-transmitters of airway smooth-muscle relaxation: analysis in neuronal nitric oxide synthase knockout mice.

  2003cited by this paper
• Bronchodilation by an inhaled VPAC2 receptor agonist in patients with stable asthma

  2003cited by this paper
• Global tuberculosis control: surveillance planning financing. WHO report 2003.

  2003cited by this paper
• Vector-based RNAi, a novel tool for isoform-specific knock-down of VEGF and anti-angiogenesis gene therapy of cancer.

  2003cited by this paper
• Small interfering RNA-induced suppression of MDR1 (P-glycoprotein) restores sensitivity to multidrug-resistant cancer cells.

  2003cited by this paper
• Alpha-1-antitrypsin expression in the lung is increased by airway delivery of gene-transfected macrophages

  2003cited by this paper
• Targeting the lung: preclinical and comparative evaluation of anticancer aerosols in dogs with naturally occurring cancers.

  2003cited by this paper
• Pulmonary alveolar proteinosis.

  2003cited by this paper
• Small interfering RNAs suppress the expression of endogenous and GFP-fused epidermal growth factor receptor (erbB1) and induce apoptosis in erbB1-overexpressing cells.

  2003cited by this paper
• Specific inhibition of bcr-abl gene expression by small interfering RNA.

  2003cited by this paper
• Autoantibodies against granulocyte macrophage colony-stimulating factor are diagnostic for pulmonary alveolar proteinosis.

  2002cited by this paper
• Gene silencing using micro-RNA designed hairpins.

  2002cited by this paper
• Worldwide racial and ethnic distribution of alpha1-antitrypsin deficiency: summary of an analysis of published genetic epidemiologic surveys.

  2002cited by this paper

• Comparative hygroscopic aerosol particle sizing measurements of the hygroscopic growth of inhaled pharmaceutical ingredients

  2025cites this paper
• Development of Inhaled Dry Powder Formulations for Naked Nucleic Acids 
without Transfection Agents

  2025cites this paper
• Inhalation delivery of nucleic acid gene therapies in preclinical drug development

  2023cites this paper
• Exploring the role of electrostatic deposition on inhaled aerosols in alveolated microchannels

  2023cites this paper
• Delivery of nucleic acids using nanomaterials

  2023cites this paper
• AMELIORATION IN APPROACHES FOR ENHANCED PULMONARY DRUG DELIVERY

  2023cites this paper
• In Vitro Evaluation of Nebulized Pharmaceutical Aerosol Delivery to the Lungs Using a New Heated Dryer System (HDS)

  2022cites this paper
• A OVERVIEW OF AN DRY POWDER INHALATION DOSAGE FORM

  2022cites this paper
• Lipid Nanoparticles as Delivery Vehicles for Inhaled Therapeutics

  2022cites this paper
• Consideration of Metal Organic Frameworks for Respiratory Delivery

  2021cites this paper
• Revisiting Airflow and Aerosol Transport Phenomena in the Deep Lungs with Microfluidics.

  2021cites this paper
• Combination of pseudoephedrine and emodin ameliorates LPS-induced acute lung injury by regulating macrophage M1/M2 polarization through the VIP/cAMP/PKA pathway

  2021cites this paper
• Inhalable Nanobody (PiN-21) prevents and treats SARS-CoV-2 infections in Syrian hamsters at ultra-low doses

  2021cites this paper
• Advanced human-relevant in vitro pulmonary platforms for respiratory therapeutics.

  2021cites this paper
• Inhalable Nanobody (PiN-21) prevents and treats SARS-CoV-2 infections in Syrian hamsters at ultra-low doses

  2021cites this paper
• CFD Guided Optimization of Nose-to-Lung Aerosol Delivery in Adults: Effects of Inhalation Waveforms and Synchronized Aerosol Delivery

  2020cites this paper
• Developments in systems biology: implications for health and biochemical security

  2020cites this paper
• Development of lentiviral airway gene therapy aerosol delivery techniques for cystic fibrosis

  2019cites this paper
• Targeted Gene Delivery through the Respiratory System: Rationale for Intratracheal Gene Transfer

  2019influential citation
• Devices for Improved Delivery of Nebulized Pharmaceutical Aerosols to the Lungs

  2019cites this paper
• Advanced in vitro lung-on-chip platforms for inhalation assays: From prospect to pipeline.

  2019cites this paper
• Quantitative Imaging of Regional Aerosol Deposition, Lung Ventilation and Morphology by Synchrotron Radiation CT

  2018cites this paper
• Gene Therapy for Cystic Fibrosis: Hurdles to Overcome for Successful Clinical Translation

  2018cites this paper
• Dual-Use Nano-Neurotechnology:

  2018cites this paper
• DNA Vaccines—How Far From Clinical Use?

  2018cites this paper
• Lessons learned from lung and liver in-vivo gene therapy: implications for the future

  2018cites this paper
• Vasoactive intestinal peptide overexpression mediated by lentivirus attenuates lipopolysaccharide‐induced acute lung injury in mice by inhibiting inflammation

  2018cites this paper
• University of Groningen Dry powder inhalation : past , present and future

  2017cites this paper
• One (sub‐)acinus for all: Fate of inhaled aerosols in heterogeneous pulmonary acinar structures

  2017cites this paper
• Pulmonary surfactant and nanocarriers: Toxicity versus combined nanomedical applications.

  2017cites this paper
• Dry powder inhalation: past, present and future

  2017cites this paper
• New strategies to deliver drugs for the local treatment of severe pulmonary diseases

  2016cites this paper
• Selected Engineering and Physicochemical Aspects of Systemic Drug Delivery by Inhalation.

  2016cites this paper
• Opportunities and Challenges for Host-Directed Therapies in Tuberculosis.

  2016cites this paper
• Macrophage Gene Therapy: opening novel therapeutic avenues for immune disorders

  2015cites this paper